Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1072

1.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
2.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

3.

Management of HIV infection during pregnancy.

McGowan JP, Shah SS.

Curr Opin Obstet Gynecol. 2000 Oct;12(5):357-67. Review.

PMID:
11111877
4.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
5.

Prevention of mother-to-child transmission of HIV infection.

Thorne C, Newell ML.

Curr Opin Infect Dis. 2004 Jun;17(3):247-52. Review.

PMID:
15166829
6.

Genotypic resistance tests for the management of the HIV-infected pregnant woman.

Bassetti D, Cargnel A.

Scand J Infect Dis Suppl. 2003;106:70-4. Review.

PMID:
15000589
7.

Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.

Makokha EP, Songok EM, Orago AA, Koech DK, Chemtai AK, Kobayashi N, Mpoke S, Tukei PM, Andayi FA, Lihana RW, Adungo NI, Vulule JM.

East Afr Med J. 2002 Nov;79(11):567-73.

PMID:
12630488
8.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
9.
10.

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.

Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.

Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S42-55. Review.

PMID:
17825650
11.

Strategies to prevent mother-to-child transmission of HIV.

McIntyre J.

Curr Opin Infect Dis. 2006 Feb;19(1):33-8. Review.

PMID:
16374215
12.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
13.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort.

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
14.

Mother-to-child transmission of HIV infection and its prevention.

Thorne C, Newell ML.

Curr HIV Res. 2003 Oct;1(4):447-62. Review.

PMID:
15049430
15.

Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.

Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ; Pediatrics AIDS Clinical Trials Group 288 Protocol Team.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):170-81.

PMID:
12571527
16.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

17.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
18.

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK; NISDI Perinatal Study Group.

Obstet Gynecol. 2007 Jun;109(6):1358-67.

PMID:
17540808
19.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
20.

Supplemental Content

Support Center